Looking for a Mounjaro Alternative?

Quick answer

Mounjaro is Eli Lilly's brand-name tirzepatide, approved for type 2 diabetes and prescribed off-label for weight loss. It costs roughly $1,023/mo without insurance. LYV prescribes compounded tirzepatide -- the identical active molecule -- starting at $197/mo. Same compound, same mechanism, same clinical evidence. The difference is the manufacturer and the price.

What Mounjaro offers

Mounjaro is the original tirzepatide product and it earned its reputation. The SURMOUNT trials demonstrated 22.5% body weight loss -- the most impressive results of any weight loss medication to date. Eli Lilly's manufacturing is world-class, and the pre-filled auto-injector pens are well-designed and easy to use. Mounjaro has FDA approval for type 2 diabetes, and Zepbound (same compound) has approval for weight management. If your insurance fully covers it, Mounjaro is an excellent product.

Mounjaro vs LYV

MounjaroLYV
Active compoundTirzepatideTirzepatide
ManufacturerEli LillyLicensed US compounding pharmacy
Monthly cost~$1,023/mo retailFrom $197/mo
InsuranceCovered by some plansCash-pay (no insurance needed)
FDA approvalYes (type 2 diabetes)Pharmacy FDA-regulated; compound not individually approved
Delivery formatPre-filled auto-injector penPre-dosed pens
Dose flexibility6 fixed doses (2.5-15mg)Custom dosing per provider
Includes consultationNo (separate doctor visit)Yes, included

Where LYV differs

  • Cost is the primary difference. Compounded tirzepatide through LYV costs roughly 80% less than Mounjaro retail pricing. The active molecule is identical.
  • LYV includes the provider consultation, prescription, and shipping in one flat monthly price. Mounjaro requires a separate doctor visit and pharmacy interaction.
  • Compounded tirzepatide allows custom dosing. Your provider can prescribe exact doses that may fall between Eli Lilly's six fixed pen sizes.
  • LYV also offers NAD+, sermorelin, glutathione, ED treatments, and hair therapy. If your health goals go beyond weight loss, everything is managed by one provider.

Frequently asked questions

Is compounded tirzepatide as effective as Mounjaro?

+

The active molecule is the same. Tirzepatide is tirzepatide. Clinical results depend on the compound, the dose, and adherence -- not the label on the package. At equivalent doses, compounded tirzepatide produces the same mechanism of action and expected outcomes.

Why is Mounjaro so expensive?

+

Brand-name drug pricing reflects R&D investment, FDA approval costs, marketing, and profit margins for a publicly traded company. Compounding pharmacies do not carry those costs. They source pharmaceutical-grade tirzepatide and prepare it under regulated conditions at dramatically lower overhead.

Will my insurance cover compounded tirzepatide?

+

Most insurance plans do not cover compounded medications. LYV's pricing is designed for cash-pay patients. At $197/mo, it is still significantly less than most Mounjaro copays for patients without full coverage.

Should I stay on Mounjaro if my insurance covers it?

+

If your insurance covers Mounjaro with a low copay, staying on it is reasonable. The compound is identical. If your coverage changes, your copay increases, or you lose access, LYV's compounded tirzepatide is a direct substitution at a fraction of the cash price.

How do I switch from Mounjaro to LYV?

+

Take the LYV quiz and share your current Mounjaro dose during the consultation. Your LYV provider will prescribe compounded tirzepatide at the equivalent dose. There is no washout period. Most patients switch seamlessly between doses.

See how LYV matches your goals

Take a 2-minute quiz. Get a personalized protocol.

Licensed US pharmacy|Batch-tested|Cancel anytime